PMDI
Psychemedics Corporation
Price Chart
Latest Quote
$2.20
+0.00 (+0.00%)
Current Price
| Previous Close | $2.20 |
| Open | $2.49 |
| Day High | $2.49 |
| Day Low | $2.49 |
| Volume | 99 |
Stock Information
| Shares Outstanding | 6.11M |
| Total Debt | $1.17M |
| Cash Equivalents | $1.42M |
| Revenue | $19.68M |
| Net Income | $-1.86M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $13.44M |
| EPS (TTM) | $-0.32 |
| Exchange | PNK |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $13.19M |
| Sales | $19.68M |
| Income | $-1.86M |
| Book/sh | $0.84 |
| Cash/sh | $0.23 |
| Employees | 101 |
Financial Ratios
| Quick Ratio | 1.45 |
| Current Ratio | 1.82 |
| Debt/Eq | 22.73 |
Returns & Margins
| ROA | -11.46% |
| ROE | -31.54% |
| Gross Margin | 36.07% |
| Operating Margin | 3.80% |
| Profit Margin | -9.45% |
Ownership
| Insider Ownership | 51.02% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 8.79 |
| P/S | 0.68 |
| P/B | 2.62 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.26 |
| SMA50 | $2.25 |
| SMA200 | $1.94 |
| ATR | 0.0143 |
| Shares Float | 3.00M |
| Short Float | 0.87% |
| Short Ratio | 1.71 |
| Volatility | 0.74 |
Performance History
| Week | +0.00% |
| Month | -8.33% |
| Quarter | +57.14% |
| 6 Months | +30.95% |
| YTD | +38.36% |
| Year | -2.22% |
| 3 Years | -53.02% |
| 5 Years | -71.59% |
| 10 Years | -79.06% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $2.20 | 0 |
| 2026-06-17 | $2.20 | 0 |
| 2026-06-16 | $2.20 | 0 |
| 2026-06-15 | $2.20 | 0 |
| 2026-06-12 | $2.20 | 0 |
| 2026-06-11 | $2.20 | 200 |
| 2026-06-10 | $2.20 | 0 |
| 2026-06-09 | $2.20 | 0 |
| 2026-06-08 | $2.20 | 0 |
| 2026-06-05 | $2.20 | 0 |
| 2026-06-04 | $2.20 | 0 |
| 2026-06-03 | $2.20 | 0 |
| 2026-06-02 | $2.20 | 0 |
| 2026-06-01 | $2.20 | 300 |
| 2026-05-29 | $2.40 | 0 |
| 2026-05-28 | $2.40 | 0 |
| 2026-05-27 | $2.40 | 0 |
| 2026-05-26 | $2.40 | 0 |
| 2026-05-22 | $2.40 | 0 |
| 2026-05-21 | $2.40 | 0 |
| 2026-05-20 | $2.40 | 0 |
| 2026-05-19 | $2.40 | 0 |
About Psychemedics Corporation
Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. The company provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising aka K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Dallas, Texas.
đ° Latest News
No news articles available at the moment. Check back later for updates on PMDI.
Period:
Loading...
Income Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $12,584,000 | $13,685,000 | $15,949,000 | $14,645,000 |
| Cost Of Revenue | $12,584,000 | $13,685,000 | $15,949,000 | $14,645,000 |
| Total Revenue | $19,685,000 | $22,098,000 | $25,240,000 | $24,909,000 |
| Operating Revenue | $19,569,000 | $21,977,000 | $25,084,000 | $24,741,000 |
| Expenses | ||||
| Interest Expense | $26,000 | $17,000 | - | - |
| Total Expenses | $21,578,000 | $25,019,000 | $26,323,000 | $24,700,000 |
| Other Income Expense | $3,000 | $-500,000 | $43,000 | $-1,030,000 |
| Other Non Operating Income Expenses | $5,000 | $7,000 | $43,000 | $-61,000 |
| Net Non Operating Interest Income Expense | $-26,000 | $-17,000 | - | - |
| Interest Expense Non Operating | $26,000 | $17,000 | - | - |
| Operating Expense | $8,994,000 | $11,334,000 | $10,374,000 | $10,055,000 |
| Selling And Marketing Expense | $2,550,000 | $2,998,000 | $3,191,000 | $2,799,000 |
| General And Administrative Expense | $5,695,000 | $7,192,000 | $5,857,000 | $6,126,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Net Interest Income | $-26,000 | $-17,000 | - | - |
| Interest Income | $0 | $0 | - | - |
| Normalized Income | $-1,859,058 | $-3,753,470 | $-1,084,000 | $119,890 |
| Net Income From Continuing And Discontinued Operation | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Total Operating Income As Reported | $-1,893,000 | $-2,921,000 | $-1,083,000 | $209,000 |
| Net Income Common Stockholders | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Net Income | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Net Income Including Noncontrolling Interests | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Net Income Continuous Operations | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Pretax Income | $-1,916,000 | $-3,438,000 | $-1,040,000 | $-821,000 |
| Special Income Charges | $-2,000 | $-507,000 | $0 | $-969,000 |
| Interest Income Non Operating | $0 | $0 | - | - |
| Operating Income | $-1,893,000 | $-2,921,000 | $-1,083,000 | $209,000 |
| Gross Profit | $7,101,000 | $8,413,000 | $9,291,000 | $10,264,000 |
| Per Share | ||||
| Diluted EPS | - | $-0.72 | $-0.19 | $-0.12 |
| Basic EPS | - | $-0.72 | $-0.19 | $-0.12 |
| Other | ||||
| Tax Effect Of Unusual Items | $-58 | $-106,470 | $0 | $-184,110 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $193,000 | $-244,000 | $2,233,000 | $4,868,000 |
| Total Unusual Items | $-2,000 | $-507,000 | $0 | $-969,000 |
| Total Unusual Items Excluding Goodwill | $-2,000 | $-507,000 | $0 | $-969,000 |
| Reconciled Depreciation | $2,081,000 | $2,670,000 | $3,316,000 | $3,690,000 |
| EBITDA (Bullshit earnings) | $191,000 | $-751,000 | $2,233,000 | $3,899,000 |
| EBIT | $-1,890,000 | $-3,421,000 | $-1,083,000 | $209,000 |
| Diluted NI Availto Com Stockholders | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Tax Provision | $-55,000 | $716,000 | $44,000 | $-156,000 |
| Other Special Charges | $2,000 | $507,000 | - | $969,000 |
| Research And Development | $749,000 | $1,144,000 | $1,326,000 | $1,130,000 |
| Selling General And Administration | $8,245,000 | $10,190,000 | $9,048,000 | $8,925,000 |
| Other Gand A | $5,695,000 | $7,192,000 | $5,857,000 | $6,126,000 |
| Diluted Average Shares | - | $5,740,000 | $5,705,263 | $5,589,000 |
| Basic Average Shares | - | $5,740,000 | $5,681,000 | $5,589,000 |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $5,130,000 | $6,672,000 | $10,771,000 | $12,243,000 |
| Total Assets | $8,318,000 | $12,326,000 | $18,732,000 | $21,552,000 |
| Total Non Current Assets | $3,380,000 | $5,521,000 | $8,768,000 | $11,267,000 |
| Other Non Current Assets | $455,000 | $632,000 | $823,000 | $864,000 |
| Current Assets | $4,938,000 | $6,805,000 | $9,964,000 | $10,285,000 |
| Other Current Assets | $997,000 | $1,136,000 | $1,136,000 | $1,499,000 |
| Receivables | $2,524,000 | $3,705,000 | $4,078,000 | $6,794,000 |
| Taxes Receivable | $24,000 | $18,000 | $339,000 | $2,678,000 |
| Accounts Receivable | $2,500,000 | $3,687,000 | $3,739,000 | $4,116,000 |
| Allowance For Doubtful Accounts Receivable | $-37,000 | $-64,000 | $-87,000 | $-89,000 |
| Gross Accounts Receivable | $2,537,000 | $3,751,000 | $3,826,000 | $4,205,000 |
| Cash Cash Equivalents And Short Term Investments | $1,417,000 | $1,964,000 | $4,750,000 | $1,992,000 |
| Cash And Cash Equivalents | $1,417,000 | $1,964,000 | $4,750,000 | $1,992,000 |
| Cash Financial | $1,417,000 | $1,964,000 | $4,750,000 | $1,992,000 |
| Non Current Deferred Assets | - | $0 | $691,000 | $160,000 |
| Non Current Deferred Taxes Assets | - | $0 | $691,000 | $160,000 |
| Prepaid Assets | - | - | - | $1,499,000 |
| Debt | ||||
| Total Debt | $1,166,000 | $2,298,000 | $3,574,000 | $5,127,000 |
| Long Term Debt And Capital Lease Obligation | $477,000 | $945,000 | $2,243,000 | $3,479,000 |
| Current Debt And Capital Lease Obligation | $689,000 | $1,353,000 | $1,331,000 | $1,648,000 |
| Current Debt | $209,000 | $305,000 | $294,000 | $664,000 |
| Other Current Borrowings | - | $305,000 | $294,000 | $664,000 |
| Long Term Debt | - | - | $305,000 | $599,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,188,000 | $5,654,000 | $7,961,000 | $9,309,000 |
| Total Non Current Liabilities Net Minority Interest | $477,000 | $945,000 | $2,243,000 | $3,479,000 |
| Current Liabilities | $2,711,000 | $4,709,000 | $5,718,000 | $5,830,000 |
| Current Notes Payable | $209,000 | $0 | - | - |
| Payables And Accrued Expenses | $1,683,000 | $2,716,000 | $3,945,000 | $3,675,000 |
| Payables | $487,000 | $1,305,000 | $1,219,000 | $1,194,000 |
| Total Tax Payable | $25,000 | $553,000 | $771,000 | $200,000 |
| Accounts Payable | $462,000 | $752,000 | $448,000 | $994,000 |
| Non Current Deferred Liabilities | - | - | - | $0 |
| Non Current Deferred Taxes Liabilities | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $5,130,000 | $6,672,000 | $10,771,000 | $12,243,000 |
| Total Equity Gross Minority Interest | $5,130,000 | $6,672,000 | $10,771,000 | $12,243,000 |
| Stockholders Equity | $5,130,000 | $6,672,000 | $10,771,000 | $12,243,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,634,000 | $-1,634,000 | $-1,634,000 | $-1,634,000 |
| Other Equity Adjustments | $-1,634,000 | $-1,634,000 | $-1,634,000 | $-1,634,000 |
| Retained Earnings | $-18,634,000 | $-16,773,000 | $-11,820,000 | $-9,550,000 |
| Other | ||||
| Treasury Shares Number | $668,000 | $668,000 | $668,000 | $668,000 |
| Ordinary Shares Number | $6,110,000 | $5,806,000 | $5,681,000 | $5,589,000 |
| Share Issued | $6,778,000 | $6,474,000 | $6,349,000 | $6,257,000 |
| Tangible Book Value | $5,130,000 | $6,672,000 | $10,771,000 | $12,243,000 |
| Invested Capital | $5,339,000 | $6,977,000 | $11,370,000 | $13,506,000 |
| Working Capital | $2,227,000 | $2,096,000 | $4,246,000 | $4,455,000 |
| Capital Lease Obligations | $957,000 | $1,993,000 | $2,975,000 | $3,864,000 |
| Total Capitalization | $5,130,000 | $6,672,000 | $11,076,000 | $12,842,000 |
| Treasury Stock | $10,082,000 | $10,082,000 | $10,082,000 | $10,082,000 |
| Additional Paid In Capital | $35,447,000 | $35,129,000 | $34,275,000 | $33,478,000 |
| Capital Stock | $33,000 | $32,000 | $32,000 | $31,000 |
| Common Stock | $33,000 | $32,000 | $32,000 | $31,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $477,000 | $945,000 | $1,938,000 | $2,880,000 |
| Current Capital Lease Obligation | $480,000 | $1,048,000 | $1,037,000 | $984,000 |
| Line Of Credit | $0 | $305,000 | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | $339,000 | $640,000 | $442,000 | $507,000 |
| Current Accrued Expenses | $1,196,000 | $1,411,000 | $2,726,000 | $2,481,000 |
| Net PPE | $2,925,000 | $4,889,000 | $7,254,000 | $10,243,000 |
| Accumulated Depreciation | $-22,166,000 | $-23,633,000 | $-21,964,000 | $-19,659,000 |
| Gross PPE | $25,091,000 | $28,522,000 | $29,218,000 | $29,902,000 |
| Leases | $3,665,000 | $3,629,000 | $3,629,000 | $3,629,000 |
| Other Properties | $12,422,000 | $16,038,000 | $16,013,000 | $16,005,000 |
| Machinery Furniture Equipment | $8,160,000 | $7,027,000 | $6,895,000 | $6,716,000 |
| Buildings And Improvements | $844,000 | $1,828,000 | $2,681,000 | $3,552,000 |
| Properties | $0 | $0 | $0 | $0 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $842,000 | $-1,637,000 | $4,703,000 | $232,000 |
| Operating Activities | ||||
| Operating Cash Flow | $929,000 | $-1,480,000 | $4,890,000 | $414,000 |
| Cash Flow From Continuing Operating Activities | $929,000 | $-1,480,000 | $4,890,000 | $414,000 |
| Operating Gains Losses | - | $131,000 | - | $-2,181,000 |
| Investing Activities | ||||
| Capital Expenditure | $-87,000 | $-157,000 | $-187,000 | $-182,000 |
| Investing Cash Flow | $-87,000 | $-159,000 | $-208,000 | $-220,000 |
| Cash Flow From Continuing Investing Activities | $-87,000 | $-159,000 | $-208,000 | $-220,000 |
| Net Other Investing Changes | - | $-2,000 | $-21,000 | $-38,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-2,563,000 | $0 | - | - |
| Issuance Of Capital Stock | $1,934,000 | $0 | - | - |
| Financing Cash Flow | $-1,389,000 | $-1,147,000 | $-1,924,000 | $-1,035,000 |
| Cash Flow From Continuing Financing Activities | $-1,389,000 | $-1,147,000 | $-1,924,000 | $-1,035,000 |
| Cash Dividends Paid | $0 | $-799,000 | $-1,186,000 | $-279,000 |
| Common Stock Dividend Paid | $0 | $-799,000 | $-1,186,000 | $-279,000 |
| Net Common Stock Issuance | $-629,000 | $0 | - | - |
| Common Stock Issuance | $1,934,000 | $0 | - | - |
| Other | ||||
| Repayment Of Debt | $-791,000 | $-294,000 | $-664,000 | $-688,000 |
| Interest Paid Supplemental Data | $23,000 | $18,000 | $33,000 | $50,000 |
| End Cash Position | $1,417,000 | $1,964,000 | $4,750,000 | $1,992,000 |
| Beginning Cash Position | $1,964,000 | $4,750,000 | $1,992,000 | $2,833,000 |
| Changes In Cash | $-547,000 | $-2,786,000 | $2,758,000 | $-841,000 |
| Proceeds From Stock Option Exercised | $31,000 | $-54,000 | $-74,000 | $-68,000 |
| Common Stock Payments | $-2,563,000 | $0 | - | - |
| Net Issuance Payments Of Debt | $-791,000 | $-294,000 | $-664,000 | $-688,000 |
| Net Short Term Debt Issuance | $-781,000 | $-294,000 | - | - |
| Short Term Debt Payments | $-781,000 | $-294,000 | - | - |
| Net Long Term Debt Issuance | $-10,000 | $0 | $-664,000 | $-688,000 |
| Long Term Debt Payments | $-10,000 | $0 | $-664,000 | $-688,000 |
| Net Intangibles Purchase And Sale | $-36,000 | $0 | - | - |
| Purchase Of Intangibles | $-36,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-51,000 | $-157,000 | $-187,000 | $-182,000 |
| Purchase Of PPE | $-51,000 | $-157,000 | $-187,000 | $-182,000 |
| Change In Working Capital | $-205,000 | $-1,726,000 | $2,317,000 | $-802,000 |
| Change In Other Current Liabilities | $-962,000 | $-1,068,000 | $-967,000 | $-1,078,000 |
| Change In Other Current Assets | $86,000 | $0 | - | - |
| Change In Payables And Accrued Expense | $-1,334,000 | $-1,031,000 | $205,000 | $1,804,000 |
| Change In Accrued Expense | $-1,044,000 | $-1,335,000 | $751,000 | $1,387,000 |
| Change In Payable | $-290,000 | $304,000 | $-546,000 | $417,000 |
| Change In Account Payable | $-290,000 | $304,000 | $-546,000 | $417,000 |
| Change In Prepaid Assets | $824,000 | $0 | $363,000 | $-585,000 |
| Change In Receivables | $1,181,000 | $373,000 | $2,716,000 | $-943,000 |
| Changes In Account Receivables | $1,187,000 | $52,000 | $377,000 | $-760,000 |
| Other Non Cash Items | $-3,000 | - | - | - |
| Stock Based Compensation | $917,000 | $908,000 | $872,000 | $743,000 |
| Deferred Tax | $0 | $691,000 | $-531,000 | $-371,000 |
| Deferred Income Tax | $0 | $691,000 | $-531,000 | $-371,000 |
| Depreciation Amortization Depletion | $2,081,000 | $2,670,000 | $3,316,000 | $3,690,000 |
| Depreciation And Amortization | $2,081,000 | $2,670,000 | $3,316,000 | $3,690,000 |
| Depreciation | $2,081,000 | $2,670,000 | $3,316,000 | $3,690,000 |
| Gain Loss On Sale Of PPE | $0 | $131,000 | $0 | $0 |
| Net Income From Continuing Operations | $-1,861,000 | $-4,154,000 | $-1,084,000 | $-665,000 |
| Issuance Of Debt | - | - | $0 | $0 |
| Income Tax Paid Supplemental Data | - | - | $0 | $405,000 |
| Effect Of Exchange Rate Changes | - | - | $0 | $0 |
| Long Term Debt Issuance | - | - | $0 | $0 |
| Sale Of PPE | - | - | $0 | $0 |
| Net Investment Purchase And Sale | - | - | - | $0 |
| Sale Of Investment | - | - | - | $0 |
Fetched: 2026-02-02